Dr. Shirin Kalyan is an Assistant Professor in the Division of Endocrinology, Department of Medicine at the University of British Columbia and the Director of Scientific Innovation at Qu Biologics, a clinical-stage Vancouver-based biotech company focused on restoring innate immune function in the context of chronic inflammatory disorders and cancer.
- Innate immune function and Host-Microbiome interactions
- Osteoimmunology and treatment of bone degenerative diseases
- Inflammation and aging
- Sex differences in disease pathophysiology
She earned her Ph.D. from the University of British Columbia in Experimental Medicine investigating the pivotal innate immune mediators of inflammation in the context of toxic shock syndrome.
Dr. Kalyan was subsequently awarded a 3-year fellowship from the Alexander von Humboldt Foundation to conduct research at the Institute of Immunology in Kiel, Germany. Her research interests include determining how to restore immune function in the context of cancer and chronic inflammatory diseases and understanding how drug therapies commonly used to treat chronic degenerative disorders affect immunity.